Overview

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

Status:
Not yet recruiting

Trial end date:
2024-03-15

Target enrollment:

Participant gender:

Summary

Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15.

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer